Presently the diagnosis of HAE nC1-INH (in the majority without an identifiable genetic cause) and AE-UNK relies on the careful exclusion of alternate causes by a specialist physician typically by therapeutic trials of antihistamines, glucocorticoids, and anti-IgE biologic therapy. The gene discussed is COL18A1; the disease is hereditary angioedema.